Publications by authors named "Martin Smid"

Claim this Profile
R
Response to comments on inclusion of cryoprecipitate, pathogen-reduced on the WHO model lists of essential medicines for adults and children: a call for action.
Jay S Epstein, Yuyun Maryuningsih, Jean-Claude Faber, W Martin Smid, Thierry Burnouf

Blood Transfus· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inclusion of cryoprecipitate, pathogen-reduced, in the WHO model lists of essential medicines for adults and children: a call for action.
Jay S Epstein, Yuyun Maryuningsih, Jean-Claude Faber, W Martin Smid, Thierry Burnouf

Blood Transfus· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to comments from the International Patient Organization for Primary Immunodeficiencies on 'Stepwise options for preparing therapeutic plasma proteins from domestic plasma in low- and middle-income countries'.
Thierry Burnouf, Jay Epstein, Jean-Claude Faber, W Martin Smid

Vox Sang· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No evidence of a "healthy vaccinee effect" in COVID-19 vaccination data from the Czech Republic.
Martin Šmíd, Vít Tuček, Rastislav Madar, Ruth Tachezy, Zdenek Hel

Int J Infect Dis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-vaccination, post-infection and hybrid immunity against severe cases of COVID-19 and long COVID after infection with SARS-CoV-2 Omicron subvariants, Czechia, December 2021 to August 2023.
Martin Šmíd, Tamara Barusová, Jiří Jarkovský, Ondřej Májek, Tomáš Pavlík

Euro Surveill· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stepwise options for preparing therapeutic plasma proteins from domestic plasma in low- and middle-income countries.
Thierry Burnouf, Jay Epstein, Jean-Claude Faber, W Martin Smid,

Vox Sang· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rotation-based schedules in elementary schools to prevent COVID-19 spread: a simulation study.
Cyril Brom, Tomáš Diviák, Jakub Drbohlav, Václav Korbel, René Levínský

Sci Rep· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood transfusion systems in various middle income countries over the world.
Hans Vrielink, W Martin Smid

Transfus Apher Sci· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood transfusion service in Georgia.
Ketevan Shermadini, Maia Alkhazashvili, Hans Vrielink, W Martin Smid, Vladimer Getia

Transfus Apher Sci· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On the contact tracing for COVID-19: A simulation study.
Luděk Berec, Tomáš Diviák, Aleš Kuběna, René Levínský, Roman Neruda

Epidemics· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive performance of multi-model ensemble forecasts of COVID-19 across European nations.
Katharine Sherratt, Hugo Gruson, Rok Grah, Helen Johnson, Rene Niehus, Martin Smid

Elife· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protection by Vaccines and Previous Infection Against the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2.
Martin Šmíd, Luděk Berec, Lenka Přibylová, Ondřej Májek, Tomáš Pavlík

J Infect Dis· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Llibre et al.
Martin Šmíd, Luděk Berec, Jan Trnka

J Infect Dis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Beran et al.
Martin Šmíd, Luděk Berec, Jan Trnka

J Infect Dis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale for supporting stepwise access to safe plasma proteins through local production in low- and middle-income countries: A commentary of an international workshop.
Thierry Burnouf, Jay Epstein, Jean-Claude Faber, Claude Tayou Tagny, Daniel Somuah, W Martin Smid

Biologicals· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protection provided by vaccination, booster doses and previous infection against covid-19 infection, hospitalisation or death over time in Czechia.
Luděk Berec, Martin Šmíd, Lenka Přibylová, Ondřej Májek, Tomáš Pavlík

PLoS One· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stepwise access to safe plasma proteins in resource-constrained countries: Local production and pathways to fractionation-Report of an International Society of Blood Transfusion Workshop.
Thierry Burnouf, Jay Epstein, Jean-Claude Faber, Martin Smid

Vox Sang· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delays, Masks, the Elderly, and Schools: First Covid-19 Wave in the Czech Republic.
Luděk Berec, Jan Smyčka, René Levínský, Eva Hromádková, Michal Šoltés

Bull Math Biol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Importance of vaccine action and availability and epidemic severity for delaying the second vaccine dose.
Luděk Berec, René Levínský, Jakub Weiner, Martin Šmíd, Roman Neruda

Sci Rep· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delays, masks, the elderly, and schools: first COVID-19 wave in the Czech Republic.
Jan Smycka, Rene Levinsky, Eva Hromadkova, Michal Soltes, Josef Slerka, Martin Smid

medRxiv· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of COVID-19 convalescent plasma in low- and middle-income countries: a call for ethical principles and the assurance of quality and safety.
Jay Epstein, W Martin Smid, Silvano Wendel, Daniel Somuah, Thierry Burnouf

Vox Sang· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma-based COVID-19 treatments in low-and middle-income countries and the risk of transfusion-transmitted infections.
Jay Epstein, W Martin Smid, Silvano Wendel, Daniel Somuah, Thierry Burnouf

NPJ Vaccines· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
False-positive viral marker results in blood donors and their unintended consequences: P. Kiely, V.C. Hoad, E.M. Wood.
Maud van Zanten, W Martin Smid, Peter van den Burg

Vox Sang· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apheresis in developing countries around the World.
Quentin Eichbaum, W Martin Smid, Robert Crookes, Norris Naim, Alfredo Mendrone

J Clin Apher· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasmapheresis rescue therapy in progressive systemic ANCA-associated vasculitis: single-center results of stepwise escalation of immunosuppression.
Anoek A E de Joode, Jan S F Sanders, W Martin Smid, Coen A Stegeman

J Clin Apher· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis